标题
Recent insights into the biology of neuroblastoma
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF CANCER
Volume 135, Issue 10, Pages 2249-2261
出版商
Wiley
发表日期
2014-08-14
DOI
10.1002/ijc.29077
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Hyperactivation of Alk induces neonatal lethality in knock-in AlkF1178L mice
- (2015) Lucille Lopez-Delisle et al. Oncotarget
- Activated Alk triggers prolonged neurogenesis and Ret upregulation providing a therapeutic target in ALK-mutated neuroblastoma
- (2015) Alex Cazes et al. Oncotarget
- High Genomic Instability Predicts Survival in Metastatic High-Risk Neuroblastoma
- (2015) Sara Stigliani et al. NEOPLASIA
- Clinical Characteristics and Outcome of Patients with Neuroblastoma Presenting Genomic Amplification of Loci Other than MYCN
- (2014) Anne Guimier et al. PLoS One
- Th-MYCN Mice with Caspase-8 Deficiency Develop Advanced Neuroblastoma with Bone Marrow Metastasis
- (2013) Tal Teitz et al. CANCER RESEARCH
- New Strategies in Neuroblastoma: Therapeutic Targeting of MYCN and ALK
- (2013) G. Barone et al. CLINICAL CANCER RESEARCH
- Recurrent pre-existing and acquired DNA copy number alterations, including focalTERTgains, in neuroblastoma central nervous system metastases
- (2013) David Cobrinik et al. GENES CHROMOSOMES & CANCER
- Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study
- (2013) Yael P Mossé et al. LANCET ONCOLOGY
- The genetic landscape of high-risk neuroblastoma
- (2013) Trevor J Pugh et al. NATURE GENETICS
- Emerging landscape of oncogenic signatures across human cancers
- (2013) Giovanni Ciriello et al. NATURE GENETICS
- Focal DNA Copy Number Changes in Neuroblastoma Target MYCN Regulated Genes
- (2013) Candy Kumps et al. PLoS One
- Breakpoint Features of Genomic Rearrangements in Neuroblastoma with Unbalanced Translocations and Chromothripsis
- (2013) Valentina Boeva et al. PLoS One
- Distinct Neuroblastoma-associated Alterations of PHOX2B Impair Sympathetic Neuronal Differentiation in Zebrafish Models
- (2013) Desheng Pei et al. PLoS Genetics
- A Simple, Highly Visual in Vivo Screen for Anaplastic Lymphoma Kinase Inhibitors
- (2012) Frederico S. L. M. Rodrigues et al. ACS Chemical Biology
- The ALKF1174L Mutation Potentiates the Oncogenic Activity of MYCN in Neuroblastoma
- (2012) Teeara Berry et al. CANCER CELL
- Activated ALK Collaborates with MYCN in Neuroblastoma Pathogenesis
- (2012) Shizhen Zhu et al. CANCER CELL
- Common Variation at BARD1 Results in the Expression of an Oncogenic Isoform That Influences Neuroblastoma Susceptibility and Oncogenicity
- (2012) K. R. Bosse et al. CANCER RESEARCH
- A Three-Gene Expression Signature Model for Risk Stratification of Patients with Neuroblastoma
- (2012) I. Garcia et al. CLINICAL CANCER RESEARCH
- Age-dependent accumulation of genomic aberrations and deregulation of cell cycle and telomerase genes in metastatic neuroblastoma
- (2012) Simona Coco et al. INTERNATIONAL JOURNAL OF CANCER
- Association of Age at Diagnosis and Genetic Mutations in Patients With Neuroblastoma
- (2012) Nai-Kong V. Cheung JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Autonomic neurocristopathy-associated mutations in PHOX2B dysregulate Sox10 expression
- (2012) Mayumi Nagashimada et al. JOURNAL OF CLINICAL INVESTIGATION
- Clinical Significance of Tumor-Associated Inflammatory Cells in Metastatic Neuroblastoma
- (2012) Shahab Asgharzadeh et al. JOURNAL OF CLINICAL ONCOLOGY
- Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes
- (2012) Jan J. Molenaar et al. NATURE
- Common variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastoma
- (2012) Sharon J Diskin et al. NATURE GENETICS
- LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression
- (2012) Jan J Molenaar et al. NATURE GENETICS
- Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma
- (2012) Mark Sausen et al. NATURE GENETICS
- Anaplastic Lymphoma Kinase (ALK) regulates initiation of transcription of MYCN in neuroblastoma cells
- (2012) C Schönherr et al. ONCOGENE
- Functional MYCN signature predicts outcome of neuroblastoma irrespective of MYCN amplification
- (2012) L. J. Valentijn et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeted Expression of Mutated ALK Induces Neuroblastoma in Transgenic Mice
- (2012) L. C. Heukamp et al. Science Translational Medicine
- Genome-wide promoter methylation analysis in neuroblastoma identifies prognostic methylation biomarkers
- (2012) Anneleen Decock et al. GENOME BIOLOGY
- Comprehensive SNP array study of frequently used neuroblastoma cell lines; copy neutral loss of heterozygosity is common in the cell lines but uncommon in primary tumors
- (2011) Hanna Kryh et al. BMC GENOMICS
- Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable/disseminated neuroblastoma (a SIOPEN collaborative study)
- (2011) G Schleiermacher et al. BRITISH JOURNAL OF CANCER
- Massive Genomic Rearrangement Acquired in a Single Catastrophic Event during Cancer Development
- (2011) Philip J. Stephens et al. CELL
- miRNA Expression Profiling Enables Risk Stratification in Archived and Fresh Neuroblastoma Tumor Samples
- (2011) K. De Preter et al. CLINICAL CANCER RESEARCH
- High ALK Receptor Tyrosine Kinase Expression Supersedes ALK Mutation as a Determining Factor of an Unfavorable Phenotype in Primary Neuroblastoma
- (2011) J. H. Schulte et al. CLINICAL CANCER RESEARCH
- Midkine and Alk signaling in sympathetic neuron proliferation and neuroblastoma predisposition
- (2011) T. Reiff et al. DEVELOPMENT
- ALK germline mutations in patients with neuroblastoma: a rare and weakly penetrant syndrome
- (2011) Franck Bourdeaut et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Genome-Wide Linkage Analysis to Identify Genetic Modifiers of ALK Mutation Penetrance in Familial Neuroblastoma
- (2011) Marcella Devoto et al. HUMAN HEREDITY
- Germline gain-of-function mutations of ALK disrupt central nervous system development
- (2011) Loïc de Pontual et al. HUMAN MUTATION
- Differential Inhibitor Sensitivity of Anaplastic Lymphoma Kinase Variants Found in Neuroblastoma
- (2011) S. C. Bresler et al. Science Translational Medicine
- Phenotype Restricted Genome-Wide Association Study Using a Gene-Centric Approach Identifies Three Low-Risk Neuroblastoma Susceptibility Loci
- (2011) Lễ B. Nguyễn et al. PLoS Genetics
- Meta-analysis of Neuroblastomas Reveals a Skewed ALK Mutation Spectrum in Tumors with MYCN Amplification
- (2010) S. De Brouwer et al. CLINICAL CANCER RESEARCH
- Accurate prediction of neuroblastoma outcome based on miRNA expression profiles
- (2010) Johannes H. Schulte et al. INTERNATIONAL JOURNAL OF CANCER
- Prognostic Impact of Gene Expression–Based Classification for Neuroblastoma
- (2010) André Oberthuer et al. JOURNAL OF CLINICAL ONCOLOGY
- Accumulation of Segmental Alterations Determines Progression in Neuroblastoma
- (2010) Gudrun Schleiermacher et al. JOURNAL OF CLINICAL ONCOLOGY
- A biology-driven approach identifies the hypoxia gene signature as a predictor of the outcome of neuroblastoma patients
- (2010) Paolo Fardin et al. Molecular Cancer
- Hypermethylation of apoptotic genes as independent prognostic factor in neuroblastoma disease
- (2010) Elena Grau et al. MOLECULAR CARCINOGENESIS
- Integrative genomics identifies LMO1 as a neuroblastoma oncogene
- (2010) Kai Wang et al. NATURE
- An integrative genomics screen uncovers ncRNA T-UCR functions in neuroblastoma tumours
- (2010) P Mestdagh et al. ONCOGENE
- High-risk neuroblastoma tumors with 11q-deletion display a poor prognostic, chromosome instability phenotype with later onset
- (2010) H. Caren et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Overall Genomic Pattern Is a Predictor of Outcome in Neuroblastoma
- (2009) Isabelle Janoueix-Lerosey et al. JOURNAL OF CLINICAL ONCOLOGY
- Mechanisms in the pathogenesis of malignant tumours in neurofibromatosis type 1
- (2009) Hilde Brems et al. LANCET ONCOLOGY
- Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH study
- (2009) Joëlle Vermeulen et al. LANCET ONCOLOGY
- Copy number variation at 1q21.1 associated with neuroblastoma
- (2009) Sharon J. Diskin et al. NATURE
- Common variations in BARD1 influence susceptibility to high-risk neuroblastoma
- (2009) Mario Capasso et al. NATURE GENETICS
- High-resolution array copy number analyses for detection of deletion, gain, amplification and copy-neutral LOH in primary neuroblastoma tumors; Four cases of homozygous deletions of the CDKN2A gene
- (2008) Helena Caren et al. BMC GENOMICS
- Characterization of amplicons in neuroblastoma: High-resolution mapping using DNA microarrays, relationship with outcome, and identification of overexpressed genes
- (2008) Anne Fix et al. GENES CHROMOSOMES & CANCER
- The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report
- (2008) Susan L. Cohn et al. JOURNAL OF CLINICAL ONCOLOGY
- Identification of ALK as a major familial neuroblastoma predisposition gene
- (2008) Yaël P. Mossé et al. NATURE
- Activating mutations in ALK provide a therapeutic target in neuroblastoma
- (2008) Rani E. George et al. NATURE
- Oncogenic mutations of ALK kinase in neuroblastoma
- (2008) Yuyan Chen et al. NATURE
- Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma
- (2008) Isabelle Janoueix-Lerosey et al. NATURE
- Chromosome 6p22 Locus Associated with Clinically Aggressive Neuroblastoma
- (2008) John M. Maris et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Constitutional Translocation t(1;17)(p36.2;q11.2) in a Neuroblastoma Patient Disrupts the Human NBPF1 and ACCN1 Genes
- (2008) Karl Vandepoele et al. PLoS One
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More